Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis

Patients who develop heart failure (HF) after an acute myocardial infarction (AMI) are at higher risk of adverse fatal and nonfatal outcomes. Studies have shown sacubitril/valsartan can further reduce the risk of cardiovascular death or hospitalization for heart failure by 20% compared with enalapri...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lang, Ding, Xiaofang, Han, Yaxiang, Lv, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754592/
https://www.ncbi.nlm.nih.gov/pubmed/35035857
http://dx.doi.org/10.1155/2022/7840852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754592/
https://www.ncbi.nlm.nih.gov/pubmed/35035857
http://dx.doi.org/10.1155/2022/7840852

Ejemplares similares